Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Gini F. Fleming, James V. Fiorica, Julia Chapman et al.|Gynecologic Oncology|2009

Cited by 297